ATE551355T1 - Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis - Google Patents
Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensisInfo
- Publication number
- ATE551355T1 ATE551355T1 AT08170016T AT08170016T ATE551355T1 AT E551355 T1 ATE551355 T1 AT E551355T1 AT 08170016 T AT08170016 T AT 08170016T AT 08170016 T AT08170016 T AT 08170016T AT E551355 T1 ATE551355 T1 AT E551355T1
- Authority
- AT
- Austria
- Prior art keywords
- ehrlichia
- compositions
- methods
- detecting antibodies
- canis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/765,739 US7087372B2 (en) | 2001-01-18 | 2001-01-18 | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE551355T1 true ATE551355T1 (de) | 2012-04-15 |
Family
ID=25074352
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08170016T ATE551355T1 (de) | 2001-01-18 | 2002-01-16 | Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis |
| AT02720810T ATE426172T1 (de) | 2001-01-18 | 2002-01-16 | Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02720810T ATE426172T1 (de) | 2001-01-18 | 2002-01-16 | Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US7087372B2 (de) |
| EP (2) | EP2056112B1 (de) |
| JP (2) | JP4384851B2 (de) |
| AT (2) | ATE551355T1 (de) |
| AU (1) | AU2002251784B2 (de) |
| CA (1) | CA2433394C (de) |
| DE (1) | DE60231607D1 (de) |
| ES (1) | ES2324401T3 (de) |
| WO (1) | WO2002057794A2 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7087372B2 (en) * | 2001-01-18 | 2006-08-08 | Idexx Laboratories, Inc. | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| US7407770B2 (en) * | 2001-01-18 | 2008-08-05 | Idexx Corporation | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| US20030129680A1 (en) * | 2001-10-31 | 2003-07-10 | O'connor Thomas Patrick | Multi-analyte assay device |
| US7183060B2 (en) * | 2005-02-22 | 2007-02-27 | Idexx Laboratories, Inc. | Peptides for detection of antibody to Ehrlichia ewingii |
| WO2006107924A2 (en) * | 2005-04-04 | 2006-10-12 | Idexx Laboratories, Inc. | Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| EP2203469A4 (de) * | 2007-09-21 | 2011-08-24 | Idexx Lab Inc | Verfahren und zusammensetzungen zum nachweis von ehrlichia chaffeensis (p120) |
| WO2009039414A2 (en) * | 2007-09-21 | 2009-03-26 | Idexx Laboratories, Inc. | Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| US20100222289A1 (en) * | 2007-10-22 | 2010-09-02 | Cfs Research Llc | Methods for diagnosis and treatment of chronic fatigue syndrome |
| EP2664344B1 (de) * | 2007-10-31 | 2019-02-27 | Idexx Laboratories, Inc. | Ehrlichia canis-diva (unterscheidung von infizierten und geimpften tieren) |
| AU2010321790B2 (en) * | 2009-11-20 | 2016-08-04 | Zoetis Services Llc | Peptides, devices, and methods for the detection of Ehrlichia antibodies |
| US9651546B2 (en) | 2012-10-11 | 2017-05-16 | Abaxis, Inc. | Peptides, devices, and methods for the detection of ehrlichia antibodies |
| US9442112B2 (en) * | 2014-04-04 | 2016-09-13 | Abaxis, Inc. | Compositions and methods for identifying Ehrlichia species |
| WO2019060695A1 (en) * | 2017-09-22 | 2019-03-28 | Kite Pharma, Inc. | CHIMERIC POLYPEPTIDES AND USES THEREOF |
| WO2019199887A1 (en) * | 2018-04-09 | 2019-10-17 | Kansas State University Research Foundation | Biosynthetic activity of the anaplasma phagocytophilum and ehrlichia chaffeensis phagosome in a host cell-free medium |
| US11046734B2 (en) | 2018-07-27 | 2021-06-29 | Research Development Foundation | Chimeric immunogenic polypeptides |
| EP3738970A3 (de) * | 2019-05-16 | 2021-02-17 | The Trustees of Columbia University in the City of New York | Serologischer test zum nachweis der exposition gegenüber und der infektion mit durch zecken übertragene erreger |
| CN117452342B (zh) * | 2023-12-26 | 2024-03-19 | 湖南力研光电科技有限公司 | 一种基于极化特征的箔条干扰检测方法 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US4676980A (en) * | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5192679A (en) | 1990-05-03 | 1993-03-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Growing ehrlichia species in a continuous cell line |
| US5401656A (en) | 1990-05-03 | 1995-03-28 | United States Of America | Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis |
| DE4100527C2 (de) * | 1991-01-10 | 2001-11-29 | Bosch Gmbh Robert | Verfahren und Vorrichtung zum Bestimmen von Aussetzern in einer Brennkraftmaschine |
| AU1970892A (en) | 1991-04-18 | 1992-11-17 | United States Of America, Represented By The Secretary, Department Of Health And Human Services, The | Identification of a new ehrlichia species from a patient suffering from ehrlichiosis |
| US5726010A (en) | 1991-07-31 | 1998-03-10 | Idexx Laboratories, Inc. | Reversible flow chromatographic binding assay |
| FR2723950B1 (fr) | 1994-08-24 | 1996-10-25 | Bio Merieux | Fragments nucleotidiques capables de s'hybrider specifiquemennt a l'adnr ou arnr des rickettsia et leur utilisation comme sondes ou amorces. |
| CA2160423A1 (en) | 1994-11-02 | 1996-05-03 | Hemant N. Joshi | Salts of nefazodone having improved dissolution rates |
| EP0839229A4 (de) * | 1995-04-13 | 1999-09-22 | Peter John Meldrum | Ausgleichselement für formsteine |
| US5976860A (en) | 1995-06-06 | 1999-11-02 | Aquila Biopharmaceuticals, Inc. | Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| US6284238B1 (en) | 1995-06-06 | 2001-09-04 | Aquila Biopharmaceuticals, Inc. | Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods |
| US5928879A (en) | 1995-08-25 | 1999-07-27 | The Regents Of The University Of Minnesota | Method of diagnosing human granulocytic Ehrlichiosis |
| US5869335A (en) | 1995-08-25 | 1999-02-09 | Regents Of The University Of Minnesota | Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae |
| US5955359A (en) | 1995-08-25 | 1999-09-21 | University Of Maryland At Baltimore | Method of growing granulocytic ehrlichiae of the Ehrlichia phagocytophila genogroup in promyelocytic leukemia cell culture, and preparing antigens and vaccines of said granulocytic ehrlichiae |
| US6015691A (en) | 1996-05-31 | 2000-01-18 | Research Development Foundation | Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis |
| US6653128B2 (en) | 1996-10-17 | 2003-11-25 | University Of Florida | Nucleic acid vaccines against rickettsial diseases and methods of use |
| US6593147B1 (en) | 1996-10-17 | 2003-07-15 | University Of Florida Research Foundation, Inc. | Nucleic acid vaccines against rickettsial diseases and methods of use |
| US6025338A (en) | 1996-10-17 | 2000-02-15 | University Of Florida | Nucleic acid vaccines against rickettsial diseases and methods of use |
| US6207169B1 (en) | 1997-03-21 | 2001-03-27 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US20020086984A1 (en) | 1997-03-21 | 2002-07-04 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6231869B1 (en) | 1997-03-21 | 2001-05-15 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| US20020068343A1 (en) | 1997-03-21 | 2002-06-06 | Reed Steven G. | Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| US6277381B1 (en) | 1997-03-21 | 2001-08-21 | Corixa Corporation | Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| US6306394B1 (en) | 1997-04-25 | 2001-10-23 | Aquila Biopharmaceuticals Inc. | Nucleic acids, proteins, and methods of use of granulocytic ehrlichia |
| EP0915980B1 (de) | 1997-04-25 | 2009-08-05 | Antigenics Inc. | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. |
| CA2304256C (en) | 1997-09-19 | 2014-12-09 | Yasuko Rikihisa | Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis |
| US6544517B1 (en) | 1998-09-18 | 2003-04-08 | The Ohio State University Research Foundation | Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| US6392023B1 (en) | 1999-03-03 | 2002-05-21 | Research Development Foundation | Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof |
| US20020115840A1 (en) | 1998-11-30 | 2002-08-22 | Walker David H. | Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof |
| US6458942B1 (en) | 1998-11-30 | 2002-10-01 | Research Development Foundation | 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof |
| US6475492B1 (en) | 1999-04-28 | 2002-11-05 | The Administrators Of The Tulane Educational Fund | Peptides and assays for the diagnosis of lyme disease |
| US6355777B1 (en) | 2000-04-28 | 2002-03-12 | Research Development Foundation | P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
| AU2001259304A1 (en) | 2000-05-01 | 2001-11-12 | Research Development Foundation | Ehrlichia chaffeensis 28 kda outer membrane protein multigene family |
| AU2001270222A1 (en) | 2000-06-27 | 2002-01-08 | Ubs Ag | Method and system for providing distributed functionality and data analysis system utilizing same |
| US7183060B2 (en) | 2005-02-22 | 2007-02-27 | Idexx Laboratories, Inc. | Peptides for detection of antibody to Ehrlichia ewingii |
| US20030129680A1 (en) * | 2001-10-31 | 2003-07-10 | O'connor Thomas Patrick | Multi-analyte assay device |
| US7407770B2 (en) * | 2001-01-18 | 2008-08-05 | Idexx Corporation | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| US20030194756A1 (en) | 2002-04-12 | 2003-10-16 | O'connor Thomas Patrick | Peptides for detection of antibody to Ehrlichia equi |
| US7087372B2 (en) * | 2001-01-18 | 2006-08-08 | Idexx Laboratories, Inc. | Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| ITRM20010445A1 (it) | 2001-07-25 | 2003-01-27 | Sigma Tau Healthscience Spa | Alfa-chetoglutarati di principi attivi e composizioni che li contengono. |
| CA2612302C (en) | 2005-06-16 | 2015-07-28 | Research Development Foundation | Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
-
2001
- 2001-01-18 US US09/765,739 patent/US7087372B2/en not_active Expired - Lifetime
-
2002
- 2002-01-16 AT AT08170016T patent/ATE551355T1/de active
- 2002-01-16 DE DE60231607T patent/DE60231607D1/de not_active Expired - Lifetime
- 2002-01-16 ES ES02720810T patent/ES2324401T3/es not_active Expired - Lifetime
- 2002-01-16 CA CA2433394A patent/CA2433394C/en not_active Expired - Lifetime
- 2002-01-16 AU AU2002251784A patent/AU2002251784B2/en not_active Expired
- 2002-01-16 EP EP08170016A patent/EP2056112B1/de not_active Expired - Lifetime
- 2002-01-16 WO PCT/US2002/001395 patent/WO2002057794A2/en active Application Filing
- 2002-01-16 JP JP2002558024A patent/JP4384851B2/ja not_active Expired - Lifetime
- 2002-01-16 EP EP02720810A patent/EP1386167B1/de not_active Expired - Lifetime
- 2002-01-16 AT AT02720810T patent/ATE426172T1/de not_active IP Right Cessation
- 2002-01-22 US US10/054,647 patent/US20020160432A1/en not_active Abandoned
- 2002-01-22 US US10/054,354 patent/US20030119082A1/en not_active Abandoned
-
2006
- 2006-08-14 US US11/503,769 patent/US7449191B2/en not_active Expired - Lifetime
- 2006-08-14 US US11/503,817 patent/US7445788B2/en not_active Expired - Lifetime
-
2009
- 2009-03-27 JP JP2009079010A patent/JP2009185037A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20030119082A1 (en) | 2003-06-26 |
| EP1386167B1 (de) | 2009-03-18 |
| EP1386167A2 (de) | 2004-02-04 |
| US7087372B2 (en) | 2006-08-08 |
| JP4384851B2 (ja) | 2009-12-16 |
| US20020160432A1 (en) | 2002-10-31 |
| WO2002057794A2 (en) | 2002-07-25 |
| AU2002251784B2 (en) | 2006-09-14 |
| EP2056112A1 (de) | 2009-05-06 |
| JP2009185037A (ja) | 2009-08-20 |
| US7445788B2 (en) | 2008-11-04 |
| DE60231607D1 (de) | 2009-04-30 |
| JP2005502586A (ja) | 2005-01-27 |
| EP2056112B1 (de) | 2012-03-28 |
| CA2433394C (en) | 2013-09-10 |
| ATE426172T1 (de) | 2009-04-15 |
| CA2433394A1 (en) | 2002-07-25 |
| WO2002057794A3 (en) | 2003-11-20 |
| US7449191B2 (en) | 2008-11-11 |
| US20070020733A1 (en) | 2007-01-25 |
| US20020177178A1 (en) | 2002-11-28 |
| ES2324401T3 (es) | 2009-08-06 |
| US20070026474A1 (en) | 2007-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE551355T1 (de) | Zusammensetzungen und verfahren zur erkennung von antikörpern gegen ehrlichia canis und ehrlichia chaffeensis | |
| ATE554107T1 (de) | Als therapeutika geeignete monovalente antikörperfragmente | |
| CY1116632T1 (el) | Εξουδετερωτες αντισωματων του τελεστη διεγερσης αποικιων κοκκιοκυτταρων μακροφαγων ανθρωπου | |
| DE60334645D1 (de) | Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung | |
| CY2019022I2 (el) | Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους | |
| NO20054836L (no) | Nogo-reseptorbindingsprotein | |
| CY1117124T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
| CY1108691T1 (el) | Πολυπεπτιδια | |
| DE602006013029D1 (de) | Anti-egfr-antikörper | |
| DE602006018424D1 (de) | Peptide zum nachweis von ehrlichia ewingii antikörper | |
| CY1110923T1 (el) | Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων | |
| DK1406656T3 (da) | Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer | |
| DE60300734D1 (de) | Anordnungen zur Vorbehandlung von Proben | |
| DE502005009389D1 (de) | Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern | |
| DE60306920D1 (de) | Vorrichtung zur bestimmung der feinheit von mineralfasern | |
| EP1832601A3 (de) | Zusammensetzungen und Verfahren für den Nachweis von Ehrlichia Canis- und Ehrlichia Chaffeensis-Antikörpern | |
| DK2327792T3 (da) | Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme | |
| DK1875237T3 (da) | Docetaxel-immunassay | |
| ATE498134T1 (de) | Nachweis von staphylococcus | |
| DE60321041D1 (de) | Antikörper gegen krebsantigen tmeff2 und seine anwendungen | |
| DE602004024921D1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs | |
| ATE539746T1 (de) | Zusammensetzung zur verbesserung von kognition und gedächtnis | |
| DE602004023199D1 (de) | Fluoreszenzprotein und pigmentprotein | |
| ATE408832T1 (de) | Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper | |
| DE602004016906D1 (de) | Reagenz zum Nachweis von anti-Phospholipid Antikörper |